Trade Recordati SPA - RECm CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.15 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.024161% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.020283% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 20% | ||||||||
Stock exchange | Italy | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Recordati Industria Chimica e Farmaceutica SpA ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 40.54 |
Open* | 40.34 |
1-Year Change* | -18.32% |
Day's Range* | 40.06 - 40.67 |
52 wk Range | 34.52-50.50 |
Average Volume (10 days) | 166.81K |
Average Volume (3 months) | 4.37M |
Market Cap | 8.52B |
P/E Ratio | 25.62 |
Shares Outstanding | 205.46M |
Revenue | 1.80B |
EPS | 1.59 |
Dividend (Yield %) | 2.74779 |
Beta | 0.22 |
Next Earnings Date | Feb 21, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jan 27, 2023 | 40.65 | 0.34 | 0.84% | 40.31 | 40.67 | 39.95 |
Jan 26, 2023 | 40.54 | -0.66 | -1.60% | 41.20 | 41.43 | 40.45 |
Jan 25, 2023 | 40.84 | -0.24 | -0.58% | 41.08 | 41.11 | 40.34 |
Jan 24, 2023 | 41.30 | -0.17 | -0.41% | 41.47 | 41.61 | 41.06 |
Jan 23, 2023 | 41.32 | -0.40 | -0.96% | 41.72 | 41.75 | 40.87 |
Jan 20, 2023 | 41.62 | 0.01 | 0.02% | 41.61 | 42.13 | 41.50 |
Jan 19, 2023 | 41.64 | -0.40 | -0.95% | 42.04 | 42.32 | 41.54 |
Jan 18, 2023 | 42.01 | 0.35 | 0.84% | 41.66 | 42.31 | 41.44 |
Jan 17, 2023 | 41.83 | 1.40 | 3.46% | 40.43 | 41.96 | 39.95 |
Jan 16, 2023 | 40.03 | -0.12 | -0.30% | 40.15 | 40.31 | 39.92 |
Jan 13, 2023 | 40.05 | 0.66 | 1.68% | 39.39 | 40.26 | 39.35 |
Jan 12, 2023 | 39.19 | 0.53 | 1.37% | 38.66 | 39.23 | 38.59 |
Jan 11, 2023 | 38.78 | -0.21 | -0.54% | 38.99 | 39.20 | 38.75 |
Jan 10, 2023 | 39.01 | 0.20 | 0.52% | 38.81 | 39.27 | 38.77 |
Jan 9, 2023 | 39.21 | 0.53 | 1.37% | 38.68 | 39.22 | 38.54 |
Jan 6, 2023 | 38.49 | 0.26 | 0.68% | 38.23 | 38.59 | 38.09 |
Jan 5, 2023 | 38.32 | -0.40 | -1.03% | 38.72 | 38.75 | 38.19 |
Jan 4, 2023 | 38.85 | -0.11 | -0.28% | 38.96 | 39.27 | 38.72 |
Jan 3, 2023 | 38.78 | -0.31 | -0.79% | 39.09 | 39.58 | 38.66 |
Jan 2, 2023 | 38.83 | 0.08 | 0.21% | 38.75 | 39.04 | 38.66 |
Recordati SPA Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 1153.94 | 1288.12 | 1352.23 | 1481.85 | 1448.87 | 1580.07 |
Revenue | 1153.94 | 1288.12 | 1352.23 | 1481.85 | 1448.87 | 1580.07 |
Cost of Revenue, Total | 360.959 | 382.754 | 395.569 | 436.901 | 406.831 | 427.727 |
Gross Profit | 792.983 | 905.369 | 956.666 | 1044.95 | 1042.04 | 1152.35 |
Total Operating Expense | 826.519 | 881.631 | 910.016 | 1016.58 | 979.851 | 1089.88 |
Selling/General/Admin. Expenses, Total | 369.219 | 396.375 | 401.219 | 445.586 | 421.857 | 480.889 |
Research & Development | 83.71 | 100.256 | 67.093 | 77.081 | 146.236 | 166.138 |
Unusual Expense (Income) | 12.631 | 2.246 | 3.535 | 0.264 | 4.927 | 14.478 |
Operating Income | 327.423 | 406.492 | 442.219 | 465.266 | 469.016 | 490.19 |
Interest Income (Expense), Net Non-Operating | -9.866 | -17.148 | -17.977 | -20.616 | -13.203 | -26.718 |
Other, Net | -0.275 | -0.229 | -6.307 | -0.506 | -0.157 | -0.123 |
Net Income Before Taxes | 317.282 | 389.115 | 417.935 | 444.144 | 455.656 | 463.349 |
Net Income After Taxes | 237.431 | 288.799 | 312.422 | 368.866 | 355.027 | 385.966 |
Minority Interest | -0.025 | -0.037 | -0.046 | -0.041 | -0.043 | 0 |
Net Income Before Extra. Items | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Net Income | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Income Available to Common Excl. Extra. Items | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Income Available to Common Incl. Extra. Items | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Dilution Adjustment | 0.025 | |||||
Diluted Net Income | 237.431 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
Diluted Weighted Average Shares | 209.19 | 209.096 | 209.087 | 209.084 | 209.06 | 209.082 |
Diluted EPS Excluding Extraordinary Items | 1.135 | 1.381 | 1.494 | 1.764 | 1.698 | 1.846 |
Dividends per Share - Common Stock Primary Issue | 0.7 | 0.85 | 0.92 | 1 | 1.05 | 1.1 |
Diluted Normalized EPS | 1.18018 | 1.38897 | 1.50664 | 1.76505 | 1.7131 | 1.89642 |
Depreciation / Amortization | 42.6 | 52.6 | ||||
Other Operating Expenses, Total | 4.15 | 0 | 0.652 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 384.838 | 385.997 | 385.354 | 423.885 | 419.381 |
Revenue | 384.838 | 385.997 | 385.354 | 423.885 | 419.381 |
Cost of Revenue, Total | 104.069 | 101.871 | 107.065 | 114.722 | 115.478 |
Gross Profit | 280.769 | 284.126 | 278.289 | 309.163 | 303.903 |
Total Operating Expense | 259.951 | 260.516 | 262.795 | 306.622 | 288.11 |
Selling/General/Admin. Expenses, Total | 113.409 | 117.419 | 116.236 | 133.825 | 121.733 |
Research & Development | 41.456 | 39.673 | 38.562 | 46.447 | 43.669 |
Unusual Expense (Income) | 0.774 | 0.561 | 0.487 | 12.656 | 7.115 |
Other Operating Expenses, Total | 0.243 | 0.992 | 0.445 | -1.028 | 0.115 |
Operating Income | 124.887 | 125.481 | 122.559 | 117.263 | 131.271 |
Interest Income (Expense), Net Non-Operating | -8.883 | -5.964 | -7.313 | -4.558 | -6.926 |
Other, Net | -0.01 | -0.011 | -0.01 | -0.092 | -0.027 |
Net Income Before Taxes | 115.994 | 119.506 | 115.236 | 112.613 | 124.318 |
Net Income After Taxes | 89.884 | 117.222 | 89.28 | 89.58 | 96.72 |
Minority Interest | -0.012 | -0.01 | 0.022 | 0 | |
Net Income Before Extra. Items | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Net Income | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Income Available to Common Excl. Extra. Items | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Income Available to Common Incl. Extra. Items | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Diluted Net Income | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
Diluted Weighted Average Shares | 209.005 | 209.347 | 209.142 | 208.836 | 209.351 |
Diluted EPS Excluding Extraordinary Items | 0.43 | 0.55989 | 0.42699 | 0.42895 | 0.462 |
Dividends per Share - Common Stock Primary Issue | 0 | 0.53 | 0 | 0.57 | 0 |
Diluted Normalized EPS | 0.43 | 0.55874 | 0.42699 | 0.48058 | 0.48849 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 552.233 | 773.685 | 699.931 | 809.35 | 772.951 | 850.101 |
Cash and Short Term Investments | 138.493 | 302.077 | 198.036 | 187.923 | 188.23 | 244.578 |
Cash | 117.17 | 273.343 | 172.421 | 141.384 | 175.227 | 230.924 |
Cash & Equivalents | 21.323 | 28.734 | 25.615 | 46.539 | 13.003 | 13.654 |
Total Receivables, Net | 228.9 | 282.478 | 281.276 | 374.328 | 313.859 | 350.335 |
Accounts Receivable - Trade, Net | 205.988 | 244.117 | 245.742 | 296.961 | 268.897 | 307.778 |
Total Inventory | 158.8 | 179.1 | 206.084 | 226.885 | 251.252 | 228.732 |
Prepaid Expenses | 8.062 | 6.205 | 8.121 | 10.265 | 12.574 | 15.307 |
Other Current Assets, Total | 17.978 | 3.825 | 6.414 | 9.949 | 7.036 | 11.149 |
Total Assets | 1560.74 | 2056.41 | 2161.26 | 2808.93 | 2711.65 | 2816.2 |
Property/Plant/Equipment, Total - Net | 110.202 | 103.009 | 103.582 | 133.342 | 133.25 | 131.12 |
Property/Plant/Equipment, Total - Gross | 374.684 | 376.699 | 387.858 | 437.716 | 453.036 | 462.825 |
Accumulated Depreciation, Total | -264.482 | -273.69 | -284.276 | -304.374 | -319.786 | -331.705 |
Goodwill, Net | 556.566 | 539.871 | 577.786 | 577.973 | 562.116 | 553.209 |
Intangibles, Net | 279.884 | 540.565 | 672.106 | 1161.76 | 1115.81 | 1138.79 |
Long Term Investments | 19.199 | 24.171 | 20.773 | 38.566 | 45.581 | 34.124 |
Other Long Term Assets, Total | 42.659 | 75.106 | 87.087 | 87.939 | 81.945 | 108.859 |
Total Current Liabilities | 311.31 | 375.546 | 490.742 | 586.754 | 578.464 | 626.416 |
Accounts Payable | 124.644 | 141.74 | 165.02 | 175.481 | 132.096 | 177.925 |
Accrued Expenses | 42.807 | 43.68 | 42.289 | 45.267 | 39.649 | 56.191 |
Notes Payable/Short Term Debt | 15.689 | 16.577 | 16.905 | 13.392 | 12.567 | 8.657 |
Current Port. of LT Debt/Capital Leases | 40.428 | 51.71 | 130.583 | 149.817 | 270.254 | 223.061 |
Other Current Liabilities, Total | 87.742 | 121.839 | 135.945 | 202.797 | 123.898 | 160.582 |
Total Liabilities | 656.913 | 1029.32 | 1197.87 | 1610.35 | 1435.67 | 1434.57 |
Total Long Term Debt | 293.644 | 612.462 | 640.647 | 937.344 | 778.238 | 760.473 |
Long Term Debt | 293.644 | 612.462 | 640.647 | 937.344 | 760.587 | 745.382 |
Deferred Income Tax | 27.659 | 17.554 | 43.486 | 43.172 | 41.219 | 26.675 |
Minority Interest | 0.11 | 0.147 | 0.193 | 0.234 | 0.277 | 0 |
Other Liabilities, Total | 24.19 | 23.608 | 22.804 | 42.849 | 37.473 | 21.01 |
Total Equity | 903.83 | 1027.09 | 963.393 | 1198.58 | 1275.98 | 1381.62 |
Common Stock | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 |
Additional Paid-In Capital | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 |
Retained Earnings (Accumulated Deficit) | 956.46 | 1064.13 | 1161.69 | 1334.42 | 1473.6 | 1612.81 |
Treasury Stock - Common | -76.761 | -17.029 | -145.608 | -93.48 | -87.516 | -126.981 |
Other Equity, Total | -85.729 | -129.871 | -162.545 | -152.223 | -219.962 | -214.06 |
Total Liabilities & Shareholders’ Equity | 1560.74 | 2056.41 | 2161.26 | 2808.93 | 2711.65 | 2816.2 |
Total Common Shares Outstanding | 205.234 | 208.262 | 204.379 | 204.959 | 206.296 | 205.911 |
Capital Lease Obligations | 17.651 | 15.091 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 861.321 | 907.382 | 958.115 | 850.101 | 961.621 |
Cash and Short Term Investments | 250.085 | 271.869 | 341.926 | 244.578 | 261.43 |
Cash & Equivalents | 250.085 | 271.869 | 341.926 | 244.578 | 261.43 |
Total Receivables, Net | 343.118 | 357.259 | 345.649 | 352.658 | 407.68 |
Accounts Receivable - Trade, Net | 307.91 | 304.542 | 300.769 | 307.778 | 367.012 |
Total Inventory | 243.684 | 257 | 244.501 | 228.732 | 256.489 |
Other Current Assets, Total | 24.434 | 9.067 | 26.039 | 11.149 | 36.022 |
Total Assets | 2837.47 | 2875.92 | 2929.54 | 2816.2 | 3642.95 |
Property/Plant/Equipment, Total - Net | 131.384 | 130.9 | 132.992 | 131.12 | 129.207 |
Property/Plant/Equipment, Total - Gross | 455.542 | 458.108 | 464.546 | 462.825 | 464.469 |
Accumulated Depreciation, Total | -324.158 | -327.208 | -331.554 | -331.705 | -335.262 |
Goodwill, Net | 560.466 | 559.899 | 560.309 | 553.209 | 1125.12 |
Intangibles, Net | 1143.84 | 1132.93 | 1128.04 | 1138.79 | 1292.75 |
Long Term Investments | 47.405 | 39.672 | 41.963 | 34.124 | 23.34 |
Other Long Term Assets, Total | 93.055 | 105.135 | 108.13 | 108.859 | 110.922 |
Total Current Liabilities | 628.61 | 586.368 | 610.638 | 626.416 | 725.019 |
Accounts Payable | 145.065 | 160.355 | 166.917 | 177.925 | 194.998 |
Notes Payable/Short Term Debt | 35.997 | 29.106 | 13.478 | 8.657 | 15.022 |
Current Port. of LT Debt/Capital Leases | 275.06 | 222.805 | 228.168 | 223.061 | 252.279 |
Other Current Liabilities, Total | 172.488 | 174.102 | 202.075 | 216.773 | 262.72 |
Total Liabilities | 1508.69 | 1547.83 | 1484.48 | 1434.57 | 2193.52 |
Total Long Term Debt | 800.325 | 895.648 | 824.701 | 760.473 | 1403.58 |
Long Term Debt | 800.325 | 879.552 | 808.965 | 745.382 | 1389.77 |
Deferred Income Tax | 41.11 | 27.17 | 27.787 | 26.675 | 26.909 |
Minority Interest | 0.289 | 0.299 | 0 | 0 | 0 |
Other Liabilities, Total | 38.354 | 38.343 | 21.351 | 21.01 | 38.015 |
Total Equity | 1328.78 | 1328.09 | 1445.07 | 1381.62 | 1449.43 |
Common Stock | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 |
Additional Paid-In Capital | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 |
Retained Earnings (Accumulated Deficit) | 1562.21 | 1552.6 | 1640.89 | 1612.81 | 1699.78 |
Treasury Stock - Common | -126.637 | -115.257 | -98.924 | -126.981 | -144.381 |
Other Equity, Total | -216.649 | -219.116 | -206.753 | -214.06 | -215.826 |
Total Liabilities & Shareholders’ Equity | 2837.47 | 2875.92 | 2929.54 | 2816.2 | 3642.95 |
Total Common Shares Outstanding | 205.479 | 205.909 | 206.365 | 205.911 | 205.587 |
Prepaid Expenses | 12.187 | 12.984 | |||
Capital Lease Obligations | 16.096 | 15.736 | 15.091 | 13.81 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | 237.431 | 288.799 | 312.422 | 368.866 | 355.027 | 385.966 |
Cash From Operating Activities | 255.436 | 272.711 | 357.838 | 318.7 | 403.575 | 492.129 |
Cash From Operating Activities | 12.466 | 14.186 | 13.901 | 25.17 | 25.355 | 25.294 |
Amortization | 25.466 | 33.967 | 42.959 | 53.078 | 68.317 | 72.291 |
Deferred Taxes | -5.637 | -32.422 | -6.637 | |||
Non-Cash Items | 6.919 | -11.407 | 4.697 | 102.747 | 124.979 | 113.194 |
Changes in Working Capital | -21.209 | -20.412 | -9.504 | -231.161 | -170.103 | -104.616 |
Cash From Investing Activities | -158.489 | -321.188 | -231.778 | -441.209 | -131.555 | -87.499 |
Capital Expenditures | -19.669 | -14.588 | -19.362 | -443.288 | -131.678 | -87.36 |
Other Investing Cash Flow Items, Total | -138.82 | -306.6 | -212.416 | 2.079 | 0.123 | -0.139 |
Cash From Financing Activities | -189.819 | 224.656 | -224.688 | 109.526 | -264.288 | -355.943 |
Financing Cash Flow Items | -1.679 | 3.716 | 0.439 | -2.19 | 1.74 | |
Total Cash Dividends Paid | -133.73 | -159.607 | -178.887 | -190.916 | -212.718 | -216.742 |
Issuance (Retirement) of Stock, Net | -48.886 | 30.267 | -149.552 | 26.187 | -12.17 | -59.308 |
Issuance (Retirement) of Debt, Net | -5.524 | 350.28 | 103.312 | 276.445 | -41.14 | -79.893 |
Net Change in Cash | -92.872 | 162.696 | -104.369 | -10.113 | 0.307 | 56.348 |
Foreign Exchange Effects | -13.483 | -5.741 | 2.87 | -7.425 | 7.661 | |
Cash Taxes Paid | 140.14 | 65.272 | 91.646 | |||
Cash Interest Paid | 17.597 | 18.699 | 18.279 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 89.884 | 207.106 | 296.386 | 385.966 | 96.72 |
Cash From Operating Activities | 114.135 | 213.826 | 368.622 | 492.129 | 113.431 |
Cash From Operating Activities | 6.311 | 12.633 | 18.928 | 25.294 | 6.016 |
Amortization | 18.049 | 35.873 | 53.968 | 72.291 | 18.635 |
Non-Cash Items | 31.74 | 40.95 | 73.508 | 113.194 | 35.714 |
Cash Taxes Paid | 6.302 | 46.563 | 61.599 | 91.646 | 10.653 |
Cash Interest Paid | 2.243 | 9.147 | 11.476 | 18.279 | 2.344 |
Changes in Working Capital | -31.849 | -82.736 | -74.168 | -104.616 | -43.654 |
Cash From Investing Activities | -57.132 | -66.56 | -76.89 | -87.499 | -722.27 |
Capital Expenditures | -57.317 | -66.718 | -76.744 | -87.36 | -15.599 |
Other Investing Cash Flow Items, Total | 0.185 | 0.158 | -0.146 | -0.139 | -706.671 |
Cash From Financing Activities | 1.754 | -66.585 | -143.698 | -355.943 | 571.438 |
Total Cash Dividends Paid | -0.74 | -108.699 | -109.389 | -216.742 | -6.219 |
Issuance (Retirement) of Stock, Net | -43.227 | -40.458 | -29.028 | -59.308 | -18.383 |
Issuance (Retirement) of Debt, Net | 45.721 | 82.572 | -5.281 | -79.893 | 596.04 |
Foreign Exchange Effects | 3.098 | 2.958 | 5.662 | 7.661 | 1.018 |
Net Change in Cash | 61.855 | 83.639 | 153.696 | 56.348 | -36.383 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Fimei Finanziaria Industriale Mobiliare Ed Immobiliare SpA | Holding Company | 51.82 | 108368656 | 0 | 2023-01-04 | LOW |
Mawer Investment Management Ltd. | Investment Advisor | 4.997 | 10449984 | -43916 | 2022-12-07 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 3.402 | 7114438 | 0 | 2023-01-04 | LOW |
FMR Investment Management (U.K.) Limited | Investment Advisor | 1.7918 | 3747134 | 181356 | 2022-11-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3647 | 2853934 | 21111 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2497 | 2613375 | -78568 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8274 | 1730394 | 49494 | 2021-12-31 | LOW |
La Financière de l'Echiquier | Investment Advisor | 0.618 | 1292377 | 40 | 2022-11-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5425 | 1134566 | 211 | 2022-12-31 | LOW |
BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.451 | 943207 | -6025 | 2022-12-31 | LOW |
Manulife Investment Management (North America) Limited | Investment Advisor | 0.4195 | 877356 | 17787 | 2022-11-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.3733 | 780646 | 0 | 2022-11-30 | LOW |
California Public Employees' Retirement System | Pension Fund | 0.371 | 775787 | -99342 | 2021-06-30 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.3659 | 765091 | 519 | 2022-12-31 | HIGH |
State Street Global Advisors (UK) Ltd. | Investment Advisor/Hedge Fund | 0.3616 | 756114 | -23040 | 2022-12-31 | LOW |
TD Asset Management Inc. | Investment Advisor | 0.3407 | 712591 | 1039 | 2022-12-31 | LOW |
Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 0.3311 | 692330 | 575 | 2022-11-30 | LOW |
Epoch Investment Partners, Inc. | Investment Advisor | 0.331 | 692301 | -46 | 2022-12-31 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 0.3033 | 634283 | 0 | 2022-11-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.2699 | 564451 | -101 | 2022-12-31 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Recordati Company profile
About Recordati Industria Chimica e Farma SpA
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Recordati Industria Chimica e Farma SpA revenues increased 9% to EUR1.58B. Net income increased 9% to EUR386M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from EUR1.05 to EUR1.10. Basic Earnings per Share excluding Extraordinary Items increased from EUR1.73 to EUR1.87.
Industry: | Pharmaceuticals (NEC) |
Via M. Civitali, 1
MILANO
MILANO 20148
IT
Income Statement
- Annual
- Quarterly
News

FX Weekly Outlook: USD, GBP/USD, EUR/USD Analysis
USD, GBP/USD, EUR/USD forecasts for the week ahead.
16:33, 27 January 2023
WTI, Gold, Silver – commodities weekly forecast for the week ahead
Strength to strength in the commodity space, however, topside exhaustion begins to creep in
13:53, 27 January 2023
S&P 500, Nasdaq, DAX 40, Hang Seng technical update
Can the S&P 500 hold above its 2022 descending trend line?
12:44, 26 January 2023
Amazon Q4 earnings: online retailer to feel the pinch of higher costs and slowing consumer spending
AMZN Q4 earnings preview and technical analysis
09:59, 25 January 2023
Canadian Dollar Forecast: Bank of Canada Heading Towards a Final Rate Hike
Bank of Canada expected to hike 25bps at its upcoming meeting. Focus on whether the BoC announces a pause going forward.
15:49, 24 January 2023People also watch
Still looking for a broker you can trust?
Join the 480.000+ traders worldwide that chose to trade with Capital.com